Caribou Biosciences Names Tina Albertson as Chief Medical Officer-March 2024-www.financetom.com

Caribou Biosciences Names Tina Albertson as Chief Medical Officer

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Caribou Biosciences Names Tina Albertson as Chief Medical Officer

Aug 12, 2024 9:28 AM

11:50 AM EDT, 08/12/2024 (MT Newswires) -- Caribou Biosciences ( CRBU ) said Monday it has appointed Tina Albertson as chief medical officer.

Albertson most recently served as chief medical officer and head of development at Lyell Immunopharma (LYEL).

Caribou shares were down 4.1% in recent trading.

Price: 1.86, Change: -0.08, Percent Change: -4.12

Previous page： Update: Market Chatter: Roblox Ready to Make Changes to Platform to Overturn Russia Ban Next page： Canaan Board Approves $30 Million Share Buyback

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Update: Market Chatter: Roblox Ready to Make Changes to Platform to Overturn Russia Ban

Mar 10, 2026

10:38 AM EST, 12/17/2025 (MT Newswires) -- (Updates with the company's response in the third paragraph.) Roblox ( RBLX ) is prepared to make changes to some of its features after Russian watchdog Roskomnadzor imposed a ban on the platform earlier this month over child safety issues, Reuters reported Wednesday, citing a company spokesperson. The company is ready to temporarily...

Canaan Board Approves $30 Million Share Buyback

Mar 10, 2026

10:41 AM EST, 12/17/2025 (MT Newswires) -- Canaan (CAN) said Wednesday that its board authorized a renewed $30 million share repurchase program, allowing the company to buy back American depositary shares or class A ordinary shares over the next 12 months beginning Dec. 12. The company said the renewal signals confidence in its financial strength, stronger Q3 2025 performance, and...

Plug Power Installs Electrolyzer for Cleanergy's Hydrogen Facility

Mar 10, 2026

10:39 AM EST, 12/17/2025 (MT Newswires) -- Plug Power ( PLUG ) said Wednesday it has installed a 5-megawatt GenEco electrolyzer system for Cleanergy Solutions Namibia's green hydrogen project. The electrolyzer is integrated into Cleanergy's Hydrogen Dune site, which includes a 5MW solar park and a 5.9 megawatt-hour battery energy storage system to generate renewable hydrogen, the company said. The...

Structure Therapeutics Starts Phase 1 Trial of Oral Obesity Treatment

Mar 10, 2026

10:42 AM EST, 12/17/2025 (MT Newswires) -- Structure Therapeutics ( GPCR ) started a first-in-human Phase 1 trial of ACCG-2671, an oral drug designed to activate the amylin receptor, a pathway involved in regulating appetite and weight. The study will assess the safety, tolerability, and how the drug is processed and acts in the body in both healthy volunteers and...